HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

End-stage achalasia in a patient with neurofibromatosis treated with laparoscopic Heller myotomy.

Abstract
Achalasia is an esophageal motility disorder for which the pathophysiology is only partially known for the idiopathic subtype. Many factors are known to be involved with the development of secondary achalasia. Neurofibromatosis is one of the most common autosomal dominant conditions affecting the nervous system, and 25% of those with the disease have been reported to have involvement of the gastrointestinal tract. Three cases of association between neurofibromatosis and achalasia have been reported in the literature so far. Laparoscopic Heller myotomy is the gold standard surgical treatment for patients with achalasia, whereas esophagectomy is reserved for the more advanced stages of disease. There have been reports of successful long-term results in patients with stage IV achalasia treated with Heller myotomy. We report the fourth case in the literature of association between achalasia and neurofibromatosis; it is the first time that such an association is successfully treated with laparoscopic Heller myotomy.
AuthorsFrancesco Palazzo, Salvatore Puglia, Giovanni Ciaccio, Davide Ferrara, Diego Piazza
JournalSurgical laparoscopy, endoscopy & percutaneous techniques (Surg Laparosc Endosc Percutan Tech) Vol. 21 Issue 5 Pg. e266-9 (Oct 2011) ISSN: 1534-4908 [Electronic] United States
PMID22002292 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Diagnosis, Differential
  • Endoscopy, Gastrointestinal
  • Esophageal Achalasia (diagnosis, etiology, surgery)
  • Esophagus (surgery)
  • Follow-Up Studies
  • Humans
  • Laparoscopy (methods)
  • Male
  • Muscle, Smooth (surgery)
  • Neurofibromatosis 1 (complications, diagnosis)
  • Severity of Illness Index
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: